Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • NEKTAR THERAPEUTICS Earnings Analysis

  • Earnings Summary: NKTR

    EPS (TTM): -0.19 Current P/E Ratio: -51.26316
    Last Quarter's Earnings: -0.33 Current Quarter Estimate: -0.062
    Last Fiscal Year Earnings: -1.65 Next Fiscal Year Estimate: -1.067
    Analyst Consensus: Buy Dividend Rate: 0.00
    Last Dividend: 0.00
  • Reported Quarters: NKTR

    Quarterly EPS millions
  • Seasonal Performance: NKTR